Menu
Back to Journals » Lung Cancer: Targets and Therapy » Volume 3
Original Research
Economic evaluation of pemetrexed versus erlotinib as second-line treatment of patients with advanced/metastatic non-small cell lung cancer in Greece: a cost minimization analysis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,701 | Dovepress* | 9,351+ | 1,873 | 11,224 | |
| PubMed Central* | 350 | 107 | 457 | ||
| Totals | 9,701 | 1,980 | 11,681 | ||
|
*Since 16 July 2012 +Since July 2016 |
|||||
View citations on PubMed Central and Google Scholar